Marjolein van Egmond PROF.DR. Full Professor, AII - Cancer immunology Full Professor, AII - Inflammatory diseases Full Professor, CCA - Cancer biology and immunology Full Professor, Molecular cell biology and Immunology Full Professor, Surgery PI 2004 2023 Specialization Immunotherapy, cancer, inflammatory diseases, antibodies, immunology Marjolein van Egmond is professor in Oncology and Inflammation. She is PI at the Department of Molecular Cell Biology & Immunology and staff member at the Department of Surgery. Throughout her career she has been fascinated by the role of antibodies in immunity and the activation of immune cells via antibody receptors (Fc receptors).
Marjolein VAN EGMOND PHD PhD Thomas More University of Applied Sciences, Geel Logopedie en
Marjolein van Egmond PROF.DR., (Principal Investigator) Full Professor, Molecular cell biology and Immunology (VUmc) Full Professor, AII - Inflammatory diseases (VUmc) Full Professor, CCA - Cancer biology and immunology (VUmc) Full Professor, AII - Cancer immunology (VUmc) Full Professor, Surgery (VUmc) 2004 2023 Research activity per year Overview Marjolein van Egmond Group members Amélie Bos (PhD student) Patients with inflammatory bowel disease (IBD) are characterized by the presence of auto-antibodies. However, the role of these auto-antibodies within pathology remains unclear. Marjolein Van Egmond Amsterdam, Noord-Holland, Nederland 2K volgers Meer dan 500 connecties Gemeenschappelijke connecties met Marjolein weergeven Welkom terug Wachtwoord vergeten? Word nu lid. Marjolein van Egmond Amsterdam University Medical Center | VUmc · Cancer Center Amsterdam (VUmc CCA) Connect with experts in your field Join ResearchGate to contact this researcher and connect.
Marjolein van Egmond has been awarded the Jon van Rood medal
Marjolein van Egmond is professor in Oncology and Inflammation. She is PI at the Department of Molecular Cell Biology & Immunology and staff member at the Department of Surgery. Throughout her career she has been fascinated by the role of antibodies in immunity and the activation of immune cells via antibody receptors (Fc receptors). Recently Marjolein van Egmond, professor in Oncology and Inflammation, has been granted the 2022 DSI honorary member status and received the Jon van Rood medal. Marjolein van Egmond Inflammation and cancer Innate myeloid cells, such as monocytes, macrophages and granulocytes (neutrophils), play an important role in host defence against pathogens as well as tumour cells. Our research group focuses on the diverse functions of macrophages and neutrophils, which are also referred to as inflammatory cells. Prof.dr. Marjolein van Egmond received her Ph.D. from University Medical Center Utrecht, The Netherlands in 2000 (under supervision of Prof. Dr. J.G.J. van de Winkel). Her thesis focussed on the identification the function of the human Fc receptor for immunoglobulin A (FcαRI). Since FcαRI was identified as potential target for tumour therapy, the focus of the research shifted during a short.
MARJOLEIN VAN EGMOND VUmc Cancer Center Amsterdam (VUmc CCA)
Inflammation and cancer . A primary role of phagocytic cells (e.g. neutrophils and macrophages) is phagocytosis. As such, they express a variety of receptors that recognize pathogens directly, as well as receptors that recognize complement factors (complement receptors) or antibodies (Fc receptors), which facilitates phagocytosis. For the series Onderwater Ondervraagt, Laurien Onderwater interviews Dutch scientists. In January 2023, it was the turn of our Marjolein van Egmond, immunologist at Amsterdam UMC. The article elaborates on Prof. Van Egmond's research in which she focuses on antibodies and their role in autoimmune diseases and cancer.
Authors Melissa Maria Johanna van Gool 1 2 , Marjolein van Egmond 1 2 3 Affiliations 1 Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. 2 Amsterdam institute for Infection and Immunity, Amsterdam UMC, Amsterdam, Netherlands. Marjolein van Egmond and Timo K. van den Berg authors contributed equally to this study. This article is part of a series of reviews covering Neutrophils and Friends appearing in Volume 314 of Immunological Reviews .
Immunoloog Marjolein van Egmond over het vaccineren van twaalf tot vijftienjarigen Op1 YouTube
Mandy Gruijs 1 , Celine A N Sewnath 1 , Marjolein van Egmond 2 Affiliations 1 Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam - Amsterdam Institute for Infection and Immunity, De Boelelaan 1117, Amsterdam, the Netherlands. Marjolein van Egmond professor of immunology at Amsterdam UMC and epidemiologist Susan van den Hof of RIVM were interviewed about this topic by Trouw. Isn't it time for another round of vaccinations? The RIVM's so-called response team closely examines this question, explains epidemiologist Susan van den Hof, who works at the institute..
